Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P05109 (
S100A8
)
1,212
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Calprotectin is an antimicrobial complex composed of the
S100A8
and S100A9 protein family subunits. Contributing to innate immunity, calprotectin expression is increased by interleukin-1alpha (IL-1alpha), which modulates keratinocyte differentiation.
Keratinocyte growth factor
(
KGF
) is produced by mesenchymal cells and has a mitogenic activity for epithelial cells. In this study, we investigated the effect of
KGF
on calprotectin expression in keratinocytes and modulation by IL-1alpha. Human keratinocytes were cultured with
KGF
in the presence or absence of a
KGF
receptor (KGFR) inhibitor or mitogen-activated protein kinase (MAPK) inhibitors. Calprotectin (
S100A8
/S100A9) expression was determined by northern blotting and enzyme-linked immunosorbent assay, respectively, whereas MAPK phosphorylation was analyzed by western blot analysis.
KGF
significantly decreased the expression of
S100A8
/S100A9-specific mRNAs and calprotectin protein. In the presence of
KGF
, KGFR inhibitor or extracellular-regulated kinase inhibitor restored
KGF
-downregulated expression of
S100A8
/S100A9.
KGF
increased IL-1alpha expression in keratinocytes, whereas IL-1alpha increased
KGF
expression in fibroblasts. Cocultured fibroblast and keratinocytes showed lower
S100A8
/S100A9 mRNA expression than keratinocytes alone in the presence or absence of IL-1alpha or
KGF
. These results suggest that fibroblast-derived
KGF
reduces or restricts calprotectin expression in keratinocytes, which supports our hypothesis that calprotectin expression in keratinocytes is modulated by factors associated with epithelial-mesenchymal interactions.
...
PMID:Modulation of calprotectin in human keratinocytes by keratinocyte growth factor and interleukin-1alpha. 2006 99